Cargando…
Mediation of in vivo Tumor‐neutralizing Activity by Lyt‐2(+) as Well as L3T4(+) T Cell Subsets
The present study reexamines the cell surface nature of T cells mediating in vivo protective tumor immunity with the use of anti‐L3T4 and ‐Lyt‐2 antibodies. C3H/HeN mice hyperimmune against syngeneic MH134 hepatoma or MCH‐1‐A1 fibrosarcoma were prepared by intradermal (id) inoculation of viable tumo...
Autores principales: | Yoshioka, Takayuki, Sato, Soichiro, Ogata, Masato, Sakamoto, Kohichi, Sano, Haruo, Shima, Junko, Yamamoto, Hiroshi, Fujiwara, Hiromi, Hamaoka, Toshiyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907754/ https://www.ncbi.nlm.nih.gov/pubmed/2965692 http://dx.doi.org/10.1111/j.1349-7006.1988.tb00015.x |
Ejemplares similares
-
Mechanisms for Recognition of Tumor Antigens and Mediation of Anti‐tumor Effect by Noncytolytic Lyt‐2(+) T Cell Subset
por: Sakamoto, Kohichi, et al.
Publicado: (1988) -
Selective Suppression of the Generation of Anti‐tumor L3T4(+) but Not of Lyt‐2(+) T Cell‐mediated Immunity in the Tumor‐hearing State
por: Sano, Haruo, et al.
Publicado: (1988) -
LytB1 and LytB2 of Mycobacterium tuberculosis Are Not Genetically Redundant
por: Brown, Amanda Claire, et al.
Publicado: (2015) -
Differential requirements for the induction of interleukin 2 responsiveness in L3T4+ and Lyt-2+ T cell subsets
Publicado: (1985) -
Effect of in vivo administration of Lyt antibodies. Lyt phenotype of T cells in lymphoid tissues and blocking of tumor rejection
Publicado: (1985)